speb/financial-data huggingface dataset:
RUN balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 119846000.00
RUN income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 161539000.00
RUN balance_sheet (annual, 2024-12-31) — Other Properties: 16890321000.00
RUN balance_sheet (annual, 2024-12-31) — Other Receivables: 6974000.00
RUN balance_sheet (annual, 2024-12-31) — Payables: 395678000.00
RUN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 805899000.00
RUN balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 104747000.00
RUN balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
RUN balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
RUN income_statement (annual, 2024-12-31) — Pretax Income: -4382034000.00
RUN cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 18876000.00
RUN balance_sheet (annual, 2024-12-31) — Properties: 0.00
RUN balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
RUN cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
RUN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -2701024000.00
RUN balance_sheet (annual, 2024-12-31) — Raw Materials: 357870000.00
RUN balance_sheet (annual, 2024-12-31) — Receivables: 170706000.00
RUN balance_sheet (annual, 2024-12-31) — Receivables Adjustments Allowances: -15420000.00
RUN income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1709165000.00
RUN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 620876000.00
RUN cash_flow (annual, 2024-12-31) — Repayment Of Debt: -2918603000.00
RUN income_statement (annual, 2024-12-31) — Research And Development: 39304000.00
RUN balance_sheet (annual, 2024-12-31) — Restricted Cash: 372312000.00
RUN balance_sheet (annual, 2024-12-31) — Retained Earnings: -4279866000.00
RUN income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 617162000.00
RUN income_statement (annual, 2024-12-31) — Selling General And Administration: 862289000.00
RUN balance_sheet (annual, 2024-12-31) — Share Issued: 225662000.00
RUN income_statement (annual, 2024-12-31) — Special Income Charges: -3122168000.00
RUN income_statement (quarterly, 2024-12-31) — Special Income Charges: -3122168000.00
RUN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 112825000.00
RUN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 2554207000.00
RUN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 2554207000.00
RUN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -19045224.80
RUN income_statement (annual, 2024-12-31) — Tax Provision: -26817000.00
RUN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.01
RUN balance_sheet (annual, 2024-12-31) — Total Assets: 19897884000.00
RUN balance_sheet (annual, 2024-12-31) — Total Capitalization: 15224034000.00
RUN balance_sheet (annual, 2024-12-31) — Total Debt: 13022460000.00
RUN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 4164210000.00
RUN income_statement (annual, 2024-12-31) — Total Expenses: 2610758000.00
RUN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 15733674000.00
RUN balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 18175248000.00
RUN balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 14399192000.00
RUN income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -3695207000.00
RUN income_statement (annual, 2024-12-31) — Total Unusual Items: -3122168000.00
RUN income_statement (quarterly, 2024-12-31) — Total Unusual Items: -3122168000.00
RUN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -3122168000.00
RUN income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -3122168000.00
RUN balance_sheet (annual, 2024-12-31) — Work In Process: 44213000.00
RUN balance_sheet (annual, 2024-12-31) — Working Capital: 388154000.00
RUN income_statement (quarterly, 2025-03-31) — +Operating Expense: 213732000.00
RUN income_statement (quarterly, 2025-03-31) — +Total Revenue: 504271000.00
RUN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 268908000.00
RUN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 182270000.00
RUN balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2888775000.00
RUN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 6784061000.00
RUN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 226406000.00
RUN income_statement (quarterly, 2025-03-31) — Basic EPS: 0.22
RUN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 947416000.00
RUN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -655021000.00
RUN balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 112000000.00
RUN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 23000.00
RUN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 604874000.00
RUN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 604874000.00
RUN balance_sheet (quarterly, 2025-03-31) — Cash Financial: 604874000.00
RUN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 790714000.00
RUN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -655021000.00
RUN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -104206000.00
RUN cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -15618000.00
RUN cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 27910000.00
RUN cash_flow (quarterly, 2025-03-31) — Change In Inventory: -12318000.00
RUN cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 34744000.00
RUN cash_flow (quarterly, 2025-03-31) — Change In Payable: -15618000.00
RUN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 12292000.00
RUN cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -45761000.00
RUN cash_flow (quarterly, 2025-03-31) — Change In Receivables: -6906000.00
RUN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -17949000.00
RUN cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -6906000.00
RUN cash_flow (quarterly, 2025-03-31) — Changes In Cash: 31487000.00
RUN balance_sheet (quarterly, 2025-03-31) — Common Stock: 23000.00
RUN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 2615402000.00
RUN balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 927712000.00
RUN income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 405427000.00
RUN balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 378619000.00
RUN balance_sheet (quarterly, 2025-03-31) — Current Assets: 1667213000.00
RUN balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 53975000.00
RUN balance_sheet (quarterly, 2025-03-31) — Current Debt: 250422000.00
RUN balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 304397000.00
RUN balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 142267000.00
RUN balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 142267000.00
RUN balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1261981000.00
RUN cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -110550000.00
RUN cash_flow (quarterly, 2025-03-31) — Deferred Tax: -110550000.00
RUN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 169890000.00
RUN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 169890000.00
RUN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 257911000.00
RUN income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.20
RUN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 50011000.00
RUN balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 37816000.00
RUN income_statement (quarterly, 2025-03-31) — EBIT: -160287000.00
RUN income_statement (quarterly, 2025-03-31) — EBITDA: 9603000.00
RUN cash_flow (quarterly, 2025-03-31) — End Cash Position: 978903000.00
RUN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 790714000.00
RUN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -759227000.00
RUN cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 45070000.00
RUN balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 61173000.00
RUN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 57763000.00
RUN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 18566873000.00
RUN income_statement (quarterly, 2025-03-31) — Gross Profit: 98844000.00
RUN cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
RUN income_statement (quarterly, 2025-03-31) — Interest Expense: 227434000.00
RUN income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 227434000.00
RUN cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 172332000.00
RUN balance_sheet (quarterly, 2025-03-31) — Interest Payable: 110280000.00
RUN balance_sheet (quarterly, 2025-03-31) — Inventory: 414401000.00
RUN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 16176018000.00
RUN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -655021000.00
RUN balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 81297000.00
RUN cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 1669453000.00
RUN balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 58025000.00
RUN balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 13310194000.00
RUN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 13368219000.00
RUN cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 1669453000.00
RUN cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -1021647000.00
RUN balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 81297000.00
RUN balance_sheet (quarterly, 2025-03-31) — Minority Interest: 1482119000.00
RUN income_statement (quarterly, 2025-03-31) — Minority Interests: 327182000.00
RUN cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
RUN balance_sheet (quarterly, 2025-03-31) — Net Debt: 12955742000.00
RUN income_statement (quarterly, 2025-03-31) — Net Income: 50011000.00
RUN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 50011000.00
RUN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -277171000.00
RUN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 50011000.00
RUN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 50011000.00
RUN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -277171000.00
RUN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -277171000.00
RUN income_statement (quarterly, 2025-03-31) — Net Interest Income: -227434000.00
RUN cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 647806000.00
RUN cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 647806000.00
RUN income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -227434000.00
RUN cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 142887000.00
RUN balance_sheet (quarterly, 2025-03-31) — Net PPE: 15678098000.00
RUN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -655021000.00
RUN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2615402000.00
RUN balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 738072000.00
RUN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 1931609000.00
RUN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 1529161000.00
RUN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 1431477000.00
RUN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 97684000.00
RUN income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 9603000.00
RUN income_statement (quarterly, 2025-03-31) — Normalized Income: 50011000.00
RUN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -104206000.00
RUN cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 45070000.00
RUN income_statement (quarterly, 2025-03-31) — Operating Income: -114888000.00
RUN income_statement (quarterly, 2025-03-31) — Operating Revenue: 504271000.00
RUN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 227325000.00
RUN balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 101936000.00
RUN balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 250422000.00
RUN balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 61173000.00
RUN income_statement (quarterly, 2025-03-31) — Other Gand A: 57763000.00
RUN income_statement (quarterly, 2025-03-31) — Other Income Expense: -45399000.00
RUN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 61499000.00
RUN balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 281566000.00
RUN balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 120973000.00
RUN income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -45399000.00
RUN balance_sheet (quarterly, 2025-03-31) — Other Properties: 17639161000.00
RUN balance_sheet (quarterly, 2025-03-31) — Other Receivables: 6112000.00
RUN balance_sheet (quarterly, 2025-03-31) — Payables: 306724000.00
RUN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 685343000.00
RUN balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 129974000.00
RUN income_statement (quarterly, 2025-03-31) — Pretax Income: -387721000.00
RUN cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 21000.00
RUN cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
RUN cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -655021000.00
RUN balance_sheet (quarterly, 2025-03-31) — Raw Materials: 303768000.00
RUN balance_sheet (quarterly, 2025-03-31) — Receivables: 172121000.00
RUN balance_sheet (quarterly, 2025-03-31) — Receivables Adjustments Allowances: -16261000.00
RUN income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 405427000.00
RUN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 169890000.00
RUN cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -1021647000.00
RUN income_statement (quarterly, 2025-03-31) — Research And Development: 9979000.00
RUN balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 373881000.00
RUN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -4229855000.00
RUN income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 145990000.00
RUN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 203753000.00
RUN balance_sheet (quarterly, 2025-03-31) — Share Issued: 227325000.00
RUN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 25005000.00
RUN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2615402000.00
RUN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2615402000.00
RUN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
RUN income_statement (quarterly, 2025-03-31) — Tax Provision: -110550000.00
RUN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.29
RUN balance_sheet (quarterly, 2025-03-31) — Total Assets: 20377855000.00
RUN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 15925596000.00
RUN balance_sheet (quarterly, 2025-03-31) — Total Debt: 13672616000.00
RUN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 4097521000.00
RUN income_statement (quarterly, 2025-03-31) — Total Expenses: 619159000.00
RUN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 16280334000.00
RUN balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 18710642000.00
RUN balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 15018353000.00
RUN income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -114888000.00
RUN balance_sheet (quarterly, 2025-03-31) — Work In Process: 110633000.00
RUN balance_sheet (quarterly, 2025-03-31) — Working Capital: 405232000.00
RUN income_statement (quarterly, 2025-06-30) — +Operating Expense: 232065000.00
RUN income_statement (quarterly, 2025-06-30) — +Total Revenue: 569336000.00
RUN balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 279775000.00
RUN balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 192955000.00
RUN balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -3045358000.00
RUN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 6823894000.00
RUN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 229167000.00
RUN income_statement (quarterly, 2025-06-30) — Basic EPS: 1.22
RUN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 978903000.00
RUN cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -692821000.00
RUN balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 101975000.00
RUN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 23000.00
RUN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 618057000.00
RUN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 618057000.00
RUN balance_sheet (quarterly, 2025-06-30) — Cash Financial: 618057000.00
RUN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 1018654000.00
RUN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -692821000.00
RUN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -292659000.00
RUN cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 51982000.00
RUN cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -26927000.00
RUN cash_flow (quarterly, 2025-06-30) — Change In Inventory: -76748000.00
RUN cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 53323000.00
RUN cash_flow (quarterly, 2025-06-30) — Change In Payable: 51982000.00
RUN cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 25055000.00
RUN cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -208568000.00
RUN cash_flow (quarterly, 2025-06-30) — Change In Receivables: -20233000.00
RUN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -227171000.00
RUN cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -20233000.00
RUN cash_flow (quarterly, 2025-06-30) — Changes In Cash: 33174000.00
RUN balance_sheet (quarterly, 2025-06-30) — Common Stock: 23000.00
RUN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 2926727000.00
RUN balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 997906000.00
RUN income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 449520000.00
RUN balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 372975000.00
RUN balance_sheet (quarterly, 2025-06-30) — Current Assets: 1785811000.00
RUN balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 51239000.00
RUN balance_sheet (quarterly, 2025-06-30) — Current Debt: 278531000.00
RUN balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 329770000.00
RUN balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 153498000.00
RUN balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 153498000.00
RUN balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1268642000.00
RUN cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -96103000.00
RUN cash_flow (quarterly, 2025-06-30) — Deferred Tax: -96103000.00
RUN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 189713000.00
RUN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 189713000.00
RUN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 261152000.00
RUN income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.07
RUN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 279773000.00
RUN balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 40719000.00
RUN income_statement (quarterly, 2025-06-30) — EBIT: -126777000.00
RUN income_statement (quarterly, 2025-06-30) — EBITDA: 62936000.00
RUN cash_flow (quarterly, 2025-06-30) — End Cash Position: 1012077000.00
RUN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 1018654000.00
RUN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -985480000.00
RUN cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 17555000.00
RUN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 52892000.00
RUN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 71543000.00
RUN balance_sheet (quarterly, 2025-06-30) — Gross PPE: 19277951000.00
RUN income_statement (quarterly, 2025-06-30) — Gross Profit: 119816000.00
RUN cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 0.00
RUN income_statement (quarterly, 2025-06-30) — Interest Expense: 247137000.00
RUN income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 247137000.00
RUN cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 181577000.00
RUN balance_sheet (quarterly, 2025-06-30) — Interest Payable: 124162000.00
RUN balance_sheet (quarterly, 2025-06-30) — Inventory: 491150000.00
RUN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 16960036000.00
RUN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -692821000.00
RUN balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 81297000.00
RUN cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 529662000.00
RUN balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 50736000.00
RUN balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 13754778000.00
RUN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 13805514000.00
RUN cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 529662000.00
RUN cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -105402000.00
RUN balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 81297000.00
RUN balance_sheet (quarterly, 2025-06-30) — Minority Interest: 1519495000.00
RUN income_statement (quarterly, 2025-06-30) — Minority Interests: 558757000.00
RUN balance_sheet (quarterly, 2025-06-30) — Net Debt: 13415252000.00
RUN income_statement (quarterly, 2025-06-30) — Net Income: 279773000.00
RUN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 279773000.00
RUN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -278984000.00
RUN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 279773000.00
RUN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 279773000.00
RUN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -278984000.00
RUN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -278984000.00
RUN income_statement (quarterly, 2025-06-30) — Net Interest Income: -247137000.00
RUN cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 424260000.00
RUN cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 424260000.00
RUN income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -247137000.00
RUN cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 585850000.00
RUN balance_sheet (quarterly, 2025-06-30) — Net PPE: 16232593000.00
RUN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -692821000.00
RUN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 2926727000.00
RUN balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 806441000.00
RUN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 2034212000.00
RUN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 1542146000.00
RUN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 1471088000.00
RUN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 71058000.00
RUN income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 62936000.00
RUN income_statement (quarterly, 2025-06-30) — Normalized Income: 279773000.00
RUN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -292659000.00
RUN cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 17555000.00
RUN income_statement (quarterly, 2025-06-30) — Operating Income: -112249000.00
RUN income_statement (quarterly, 2025-06-30) — Operating Revenue: 569336000.00
RUN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 230321000.00
RUN balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 96207000.00
RUN balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 278531000.00
RUN balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 52892000.00
RUN income_statement (quarterly, 2025-06-30) — Other Gand A: 71543000.00
RUN income_statement (quarterly, 2025-06-30) — Other Income Expense: -14528000.00
RUN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 77307000.00
RUN balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 289781000.00
RUN balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 167611000.00
RUN income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -14528000.00
RUN balance_sheet (quarterly, 2025-06-30) — Other Properties: 18280045000.00
RUN balance_sheet (quarterly, 2025-06-30) — Other Receivables: 10635000.00
RUN balance_sheet (quarterly, 2025-06-30) — Payables: 320494000.00
RUN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 693469000.00
RUN balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 91905000.00
RUN income_statement (quarterly, 2025-06-30) — Pretax Income: -373914000.00
RUN cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 8544000.00
RUN cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -692821000.00
RUN balance_sheet (quarterly, 2025-06-30) — Raw Materials: 451799000.00
RUN balance_sheet (quarterly, 2025-06-30) — Receivables: 186525000.00
RUN balance_sheet (quarterly, 2025-06-30) — Receivables Adjustments Allowances: -17065000.00
RUN income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 449520000.00
RUN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 189713000.00
RUN cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -105402000.00
RUN income_statement (quarterly, 2025-06-30) — Research And Development: 8063000.00
RUN balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 393872000.00
RUN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -3950082000.00
RUN income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 152459000.00
RUN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 224002000.00
RUN balance_sheet (quarterly, 2025-06-30) — Share Issued: 230321000.00
RUN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 25024000.00
RUN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2926727000.00
RUN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 2926727000.00
RUN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
RUN income_statement (quarterly, 2025-06-30) — Tax Provision: -94930000.00
RUN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
RUN balance_sheet (quarterly, 2025-06-30) — Total Assets: 21230135000.00
RUN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 16681505000.00
RUN balance_sheet (quarterly, 2025-06-30) — Total Debt: 14135284000.00
RUN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 4446222000.00
RUN income_statement (quarterly, 2025-06-30) — Total Expenses: 681585000.00
RUN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 16783913000.00
RUN balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 19444324000.00
RUN balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 15515271000.00
RUN income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -112249000.00
RUN balance_sheet (quarterly, 2025-06-30) — Work In Process: 39351000.00
RUN balance_sheet (quarterly, 2025-06-30) — Working Capital: 517169000.00
RUN income_statement (quarterly, 2025-09-30) — +Operating Expense: 239615000.00
RUN income_statement (quarterly, 2025-09-30) — +Total Revenue: 724557000.00
RUN balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 336547000.00
RUN balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 223847000.00
RUN balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -3213860000.00
RUN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 6867123000.00
RUN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 230980000.00
RUN income_statement (quarterly, 2025-09-30) — Basic EPS: 0.07
RUN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1012077000.00
RUN cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -743641000.00
RUN balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 95391000.00
RUN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 23000.00
RUN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 709148000.00
RUN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 709148000.00
RUN balance_sheet (quarterly, 2025-09-30) — Cash Financial: 709148000.00
RUN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 1008843000.00
RUN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -743641000.00
RUN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -121523000.00
RUN cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -71446000.00
RUN cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 10696000.00
RUN cash_flow (quarterly, 2025-09-30) — Change In Inventory: -78838000.00
RUN cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 248593000.00
RUN cash_flow (quarterly, 2025-09-30) — Change In Payable: -71446000.00
RUN cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -60750000.00
RUN cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -189579000.00
RUN cash_flow (quarterly, 2025-09-30) — Change In Receivables: -68609000.00
RUN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -149183000.00
RUN cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -68609000.00
RUN cash_flow (quarterly, 2025-09-30) — Changes In Cash: 143679000.00
RUN balance_sheet (quarterly, 2025-09-30) — Common Stock: 23000.00
RUN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2983902000.00
RUN balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 930018000.00
RUN income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 481291000.00
RUN balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 389478000.00
RUN balance_sheet (quarterly, 2025-09-30) — Current Assets: 2070471000.00
RUN balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 51055000.00
RUN balance_sheet (quarterly, 2025-09-30) — Current Debt: 311531000.00
RUN balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 362586000.00
RUN balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 163801000.00
RUN balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 163801000.00
RUN balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1420780000.00
RUN cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -999000.00
RUN cash_flow (quarterly, 2025-09-30) — Deferred Tax: -999000.00
RUN cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 181546000.00
RUN cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 181546000.00
RUN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 267473000.00
RUN income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.06
RUN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 16589000.00
RUN balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 44122000.00
RUN income_statement (quarterly, 2025-09-30) — EBIT: -14229000.00
RUN income_statement (quarterly, 2025-09-30) — EBITDA: 167317000.00
RUN cash_flow (quarterly, 2025-09-30) — End Cash Position: 1155756000.00
RUN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 1008843000.00
RUN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -865164000.00
RUN cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 16079000.00
RUN balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 50249000.00
RUN income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 65550000.00
RUN balance_sheet (quarterly, 2025-09-30) — Gross PPE: 19968407000.00
RUN income_statement (quarterly, 2025-09-30) — Gross Profit: 243266000.00
RUN cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
RUN income_statement (quarterly, 2025-09-30) — Interest Expense: 265788000.00
RUN income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 265788000.00
RUN cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 193408000.00
RUN balance_sheet (quarterly, 2025-09-30) — Interest Payable: 123897000.00
RUN balance_sheet (quarterly, 2025-09-30) — Inventory: 569987000.00
RUN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 17605488000.00
RUN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -743641000.00
RUN balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 81297000.00
RUN cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 2064831000.00
RUN balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 44336000.00
RUN balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 14310055000.00
RUN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 14354391000.00
RUN cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 2064831000.00
RUN cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -1330308000.00
RUN balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 81297000.00
RUN balance_sheet (quarterly, 2025-09-30) — Minority Interest: 1660677000.00
RUN income_statement (quarterly, 2025-09-30) — Minority Interests: 294434000.00
RUN balance_sheet (quarterly, 2025-09-30) — Net Debt: 13912438000.00
RUN income_statement (quarterly, 2025-09-30) — Net Income: 16589000.00
RUN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 16589000.00
RUN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -277845000.00
RUN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 16589000.00
RUN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 16589000.00
RUN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -277845000.00
RUN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -277845000.00
RUN income_statement (quarterly, 2025-09-30) — Net Interest Income: -265788000.00
RUN cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 734523000.00
RUN cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 734523000.00
RUN income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -265788000.00
RUN cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 273713000.00
RUN balance_sheet (quarterly, 2025-09-30) — Net PPE: 16754547000.00
RUN cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -743641000.00
RUN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2983902000.00
RUN balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 880778000.00
RUN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 2141672000.00
RUN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 1636408000.00
RUN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 1512898000.00
RUN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 123510000.00
RUN income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 167317000.00
RUN income_statement (quarterly, 2025-09-30) — Normalized Income: 16589000.00
RUN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -121523000.00
RUN cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 16079000.00
RUN income_statement (quarterly, 2025-09-30) — Operating Income: 3651000.00
RUN income_statement (quarterly, 2025-09-30) — Operating Revenue: 724557000.00
RUN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 231605000.00
RUN balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 96597000.00
RUN balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 311531000.00
RUN balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 50249000.00
RUN income_statement (quarterly, 2025-09-30) — Other Gand A: 65550000.00
RUN income_statement (quarterly, 2025-09-30) — Other Income Expense: -17880000.00
RUN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 79288000.00
RUN balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 296717000.00
RUN balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 169324000.00
RUN income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -17880000.00
RUN balance_sheet (quarterly, 2025-09-30) — Other Properties: 19038389000.00
RUN balance_sheet (quarterly, 2025-09-30) — Other Receivables: 42618000.00
RUN balance_sheet (quarterly, 2025-09-30) — Payables: 380669000.00
RUN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 770147000.00
RUN balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 124246000.00
RUN balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
RUN income_statement (quarterly, 2025-09-30) — Pretax Income: -280017000.00
RUN cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 607000.00
RUN cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -743641000.00
RUN balance_sheet (quarterly, 2025-09-30) — Raw Materials: 387368000.00
RUN balance_sheet (quarterly, 2025-09-30) — Receivables: 248279000.00
RUN balance_sheet (quarterly, 2025-09-30) — Receivables Adjustments Allowances: -18186000.00
RUN income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 481291000.00
RUN income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 181546000.00
RUN cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -1330308000.00
RUN income_statement (quarterly, 2025-09-30) — Research And Development: 9267000.00
RUN balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 446460000.00
RUN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -3933493000.00
RUN income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 164798000.00
RUN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 230348000.00
RUN balance_sheet (quarterly, 2025-09-30) — Share Issued: 231605000.00
RUN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 29591000.00
RUN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2983902000.00
RUN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2983902000.00
RUN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
RUN income_statement (quarterly, 2025-09-30) — Tax Provision: -2172000.00
RUN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.01
RUN balance_sheet (quarterly, 2025-09-30) — Total Assets: 22225482000.00
RUN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 17293957000.00
RUN balance_sheet (quarterly, 2025-09-30) — Total Debt: 14716977000.00
RUN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 4644579000.00
RUN income_statement (quarterly, 2025-09-30) — Total Expenses: 720906000.00
RUN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 17580903000.00
RUN balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 20155011000.00
RUN balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 16160123000.00
RUN income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 3651000.00
RUN balance_sheet (quarterly, 2025-09-30) — Work In Process: 182619000.00
RUN balance_sheet (quarterly, 2025-09-30) — Working Capital: 649691000.00
RUN income_statement (annual, 2025-12-31) — +Operating Expense: 1023427000.00
RUN income_statement (quarterly, 2025-12-31) — +Operating Expense: 338015000.00
RUN income_statement (annual, 2025-12-31) — +Total Revenue: 2956997000.00
RUN income_statement (quarterly, 2025-12-31) — +Total Revenue: 1158833000.00
RUN balance_sheet (annual, 2025-12-31) — Accounts Payable: 271021000.00
RUN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 271021000.00
RUN balance_sheet (annual, 2025-12-31) — Accounts Receivable: 191559000.00
RUN balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 191559000.00
RUN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -3548022000.00
RUN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -3548022000.00
RUN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 6899277000.00
RUN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 6899277000.00
RUN cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
RUN income_statement (annual, 2025-12-31) — Basic Average Shares: 229809000.00
RUN income_statement (quarterly, 2025-12-31) — Basic Average Shares: 232602000.00
RUN income_statement (annual, 2025-12-31) — Basic EPS: 1.96
RUN income_statement (quarterly, 2025-12-31) — Basic EPS: 0.45
RUN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 947416000.00
RUN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1155756000.00
RUN cash_flow (annual, 2025-12-31) — Capital Expenditure: -2500338000.00
RUN cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -408855000.00
RUN balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 86719000.00
RUN balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 86719000.00
RUN balance_sheet (annual, 2025-12-31) — Capital Stock: 23000.00
RUN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 23000.00
RUN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 823380000.00
RUN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 823380000.00
RUN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 823380000.00
RUN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 823380000.00
RUN balance_sheet (annual, 2025-12-31) — Cash Financial: 823380000.00
RUN balance_sheet (quarterly, 2025-12-31) — Cash Financial: 823380000.00
RUN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 3211350000.00
RUN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 393139000.00
RUN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2500338000.00
RUN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -408855000.00
RUN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -421440000.00
RUN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 96948000.00
RUN cash_flow (annual, 2025-12-31) — Change In Account Payable: -80057000.00
RUN cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -44975000.00
RUN cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 84690000.00
RUN cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 73011000.00
RUN cash_flow (annual, 2025-12-31) — Change In Inventory: -99203000.00
RUN cash_flow (quarterly, 2025-12-31) — Change In Inventory: 68701000.00
RUN cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 386263000.00
RUN cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 49603000.00
RUN cash_flow (annual, 2025-12-31) — Change In Payable: -80057000.00
RUN cash_flow (quarterly, 2025-12-31) — Change In Payable: -44975000.00
RUN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 4633000.00
RUN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 28036000.00
RUN cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -613652000.00
RUN cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -169744000.00
RUN cash_flow (annual, 2025-12-31) — Change In Receivables: -119765000.00
RUN cash_flow (quarterly, 2025-12-31) — Change In Receivables: -24017000.00
RUN cash_flow (annual, 2025-12-31) — Change In Working Capital: -441724000.00
RUN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -47421000.00
RUN cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -119765000.00
RUN cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -24017000.00
RUN cash_flow (annual, 2025-12-31) — Changes In Cash: 289572000.00
RUN cash_flow (quarterly, 2025-12-31) — Changes In Cash: 81232000.00
RUN balance_sheet (annual, 2025-12-31) — Common Stock: 23000.00
RUN balance_sheet (quarterly, 2025-12-31) — Common Stock: 23000.00
RUN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 3132484000.00
RUN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 3132484000.00
RUN balance_sheet (annual, 2025-12-31) — Construction In Progress: 767587000.00
RUN balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 767587000.00
RUN income_statement (annual, 2025-12-31) — Cost Of Revenue: 2059699000.00
RUN income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 723461000.00
RUN balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 366623000.00
RUN balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 366623000.00
RUN balance_sheet (annual, 2025-12-31) — Current Assets: 2155969000.00
RUN balance_sheet (quarterly, 2025-12-31) — Current Assets: 2155969000.00
RUN balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 49811000.00
RUN balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 49811000.00
RUN balance_sheet (annual, 2025-12-31) — Current Debt: 269510000.00
RUN balance_sheet (quarterly, 2025-12-31) — Current Debt: 269510000.00
RUN balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 319321000.00
RUN balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 319321000.00
RUN balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 171520000.00
RUN balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 171520000.00
RUN balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 171520000.00
RUN balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 171520000.00
RUN balance_sheet (annual, 2025-12-31) — Current Liabilities: 1302515000.00
RUN balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1302515000.00
RUN cash_flow (annual, 2025-12-31) — Deferred Income Tax: -167218000.00
RUN cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 40434000.00
RUN cash_flow (annual, 2025-12-31) — Deferred Tax: -167218000.00
RUN cash_flow (quarterly, 2025-12-31) — Deferred Tax: 40434000.00
RUN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 725578000.00
RUN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 184429000.00
RUN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 725578000.00
RUN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 184429000.00
RUN income_statement (annual, 2025-12-31) — Diluted Average Shares: 264465000.00
RUN income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 271243000.00
RUN income_statement (annual, 2025-12-31) — Diluted EPS: 1.71
RUN income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.38
RUN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 449947000.00